Discover the latest guidance on switching disease-modifying therapies for multiple sclerosis patients, focusing on hit-hard-and-early treatment era strategies f

Discover the latest guidance on switching disease-modifying therapies for multiple sclerosis patients, focusing on hit-hard-and-early treatment era strategies f

Discover the latest guidance on switching disease-modifying therapies for multiple sclerosis patients, focusing on hit-hard-and-early treatment era strategies…

Regular coffee intake is linked to lower disease risk, with up to 400 mg of caffeine daily considered…

Lung cancer treatment raises safety concerns with atezolizumab and consolidative thoracic radiotherapy combination.

Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.

Flu vaccination rates in the US have dropped to 43.8% for adults and children. Learn why coverage is…

Cancer patients often blur lines between cancer care and everyday medical management, requiring adaptability from oncologists and primary…

New research explores how genetic factors and polygenic risk scores can improve the difficult diagnosis of idiopathic pulmonary…

Prevent liver disease and death with HBV/HCV screening and vaccination. Learn how combining testing and early treatment improves…

Treating blood cancer in prisons requires specialized care and planning to overcome unique challenges for inmates. Learn effective…

MASH predictors reveal cardiovascular and kidney risks that drive rapid liver scarring and soaring healthcare costs, highlighting urgent…